Abstract:Neuropsychiatric disorders affect millions of people globally. Despite their high prevalence, the precise molecular mechanisms behind these conditions remain largely unclear. A complex interplay of genetic, developmental, and environmental factors may increase susceptibility to these disorders, with specific molecular changes potentially influencing disease onset and progression. Understanding these molecular pathways is crucial for deepening our knowledge of neuropsychiatric pathophysiology and for developing targeted therapies. The Research Topic Molecular Mechanisms of Neuropsychiatric Diseases is the second volume and the continuation of the first volume [1], being created in response to the high interest and positive reception it received in the first volume.This research collection aims to uncover key molecular mechanisms in neuropsychiatric disorders and explore how they might inform therapeutic strategies. The progress in understanding these disorders has been slowed by a lack of clear anatomical and molecular mechanism understanding.The papers in this collection address these obstacles by connecting signs and symptoms to underlying anatomical and molecular alterations.The review by Azevedo et al examines how the activation of the sympathoadrenal medullary system and the hypothalamic-pituitary-adrenal axis in response to stress impacts memory formation, particularly in fear and traumatic memories linked to post-traumatic stress disorder (PTSD).Catecholamines like norepinephrine (NE) and epinephrine (EPI) play key roles in adaptive responses to stress and are involved in contextual fear memory enhancement through β2-adrenoceptor (β2-AR) activation [2], influencing the brain via the vagus nerve and blood glucose changes [3,4]. This review highlights that EPI is particularly influential in fear memories, activating the hippocampal Nr4a2 mRNA expression related to cAMP response element-binding protein (CREB), which plays a significant role in contextual fear memory consolidation under stressful conditions [5]. An imbalance in this system, especially over-active sympathetic responses, contributes to the persistence of traumatic memories in PTSD, with some patients [6] and animal PTSD models showing elevated catecholamine levels [7]. The authors suggest that treatments such as sotalol, a β-AR blocker [8], and nepicastat, a dopamine β-hydroxylase inhibitor [9], could reduce PTSD risk by preventing the consolidation of traumatic memories. These drugs appear to regulate gene expression in the hippocampus (Nr4a, Npas4 or Bdnf), potentially fostering more neutral contextual memories [8,9]. These treatment approaches, combined with therapy, may help PTSD patients build resilience and cope with trauma by down-regulating excessive catecholamine effects and dysregulated gene activity.A brief research report article by Bartsch et al investigates how traumatic stress leads to persistent neural changes, focusing on synaptic plasticity in a pathway between the neurons of the posterior ventral segment of the medial amygdala and the ventrolateral segment of the ventromedial hypothalamus. Using the mGRASP imaging technique, researchers observed an increase in synapse formation in this pathway in mice exposed to acute stress compared to controls. Chemogenetic inhibition of CaMKIIα-expressing neurons in the medial amygdala during stress reduced these synaptic changes, suggesting excitatory activity drives this plasticity. Additionally, blocking NMDA receptors prevented stress-induced synapse formation, highlighting an NMDA receptor-dependent mechanism. These structural changes in the medial amygdala and the ventromedial hypothalamus pathway may underlie lasting behavioural effects of traumatic stress, such as those seen in PTSD and social behaviour changes, shedding light on potential targets for intervention.affects stress responses, highlighting the role of dopaminergic neurotransmission in stress susceptibility and resilience. Researchers compared wild-type (WT) and DAT-knockout (KO) mice under chronic stress, observing that DAT-KO mice showed resistance to stress-related anxiety behaviours. These findings suggest that loss of DAT may protect against stress-induced anxiety-like behaviours, underscoring the significance of dopamine pathways in stress resilience.gene, which encodes a subunit of the GABAB receptor (GABABR) critical for inhibitory neurotransmission in the brain, impact receptor structure and function. A 7-year-old boy with Level 3 Autism Spectrum Disorder was found to carry a de novo GABBR2 p.Arg212Gln variant, identified as a variant of unknown significance via whole exome sequencing. Although treatment with the GABABR agonist baclofen showed no improvement, researchers investigated whether this variant might contribute to patient`s symptoms. Using molecular dynamics simulations and in vitro experiments, they studied how the p.Arg212Gln variant, along with -Abstract Truncated-

Selective knockdown of GABAA‐α2 subunit in the dorsal dentate gyrus in adulthood induces anxiety, learning and memory deficits and impairs synaptic plasticity

Dorsal CA1 interneurons contribute to acute stress-induced spatial memory deficits.

Preventing adolescent synaptic pruning in mouse prelimbic cortex via local knockdown of α4βδ GABAA receptors increases anxiety response in adulthood

Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

Increased Anxiety-Like Behavior and Enhanced Synaptic Efficacy in the Amygdala of GluR5 Knockout Mice.

Decreased extrasynaptic δ‐GABAA receptors in PNN‐associated parvalbumin interneurons correlates with anxiety in APP and tau mouse models of Alzheimer's disease

GABAA(δ) receptor hypofunction in the amygdala-hippocampal circuit underlies stress-induced anxiety

GABAergic implications in anxiety and related disorders

DREADD in parvalbumin interneurons of the dentate gyrus modulates anxiety, social interaction and memory extinction.

Ablation of Gabra5 Influences Corticosterone Levels and Anxiety-Like Behavior in Mice

Delta Subunit-Containing Gamma-Aminobutyric Acid A Receptor Disinhibits Lateral Amygdala and Facilitates Fear Expression in Mice.

Elucidation of the neural circuits activated by a GABAB receptor positive modulator: Relevance to anxiety

GABA - GluK1 kainate receptor interplay modulates amygdala excitability and behavioral response to chronic stress

Downregulation of kainate receptors regulating GABAergic transmission in amygdala after early life stress is associated with anxiety-like behavior in rodents

Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to Elevated Neuron Dendrite Density, Upregulated PSD95 Expression, and Abnormal Activation of the PI3K/AKT/GSK-3b and MEK/ERK Pathways

Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at α5 Subunit–Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice

Activation of 6–8-week-old new mature adult-born dentate granule cells contributes to anxiety-like behavior

The Α1 and Γ2 Subunit-Containing GABAA Receptor-Mediated Inhibitory Transmission in the Anteroventral Bed Nucleus of Stria Terminalis is Involved in the Regulation of Anxiety in Rats with Substantia Nigra Lesions

Astrocytic GABAB Receptors in Mouse Hippocampus Control Responses to Behavioral Challenges through Astrocytic BDNF

Targeted deletion of the GABRA2 gene encoding α2-subunits of GABAA receptors facilitates performance of a conditioned emotional response, and abolishes anxiolytic effects of benzodiazepines and barbiturates

Editorial: Molecular mechanisms of neuropsychiatric diseases, volume II